Prevention, Risk and Screening »Prevention Research »Prevention Research Programs

« Prevention Research Programs

Risk Assessment and Prevention Registry

With your written consent information about your family history of cancer, personal and medical history is stored in a protected database. Researchers use the information to find those factors that increase the risk for cancer and better ways to prevent the disease.

In collaboration with Fox Chase geneticist Andrew Godwin, PhD, we continue to study mutations in BRCA1, BRCA2 and other cancer-related genes. As members of the Human Genome Studies Consortium, we are exploring new directions in genetic risk assessment.

Families Understanding Risk

This study is targeted to relatives of individuals who test positive for a BRCA1/2 genetic alteration. Relatives would be asked to complete two sets of surveys, receive an educational CD and booklet and possibly participate in a telephone counseling session.
Contact: Sue Montgomery or Ruth Bingler
800-325-4145

Benign Breast Registry to Assess Valid Endpoints (BeBrave)

Women with biopsy proven benign breast disease are asked to join a substudy of the Family Risk Assessment Program. Leftover tissue from previous biopsies will be used to validate new laboratory tests.
Contact: Beth Stearman
800-325-4145

Proteomic Validation Study

Newly diagnosed ovarian cancer patients (Stage III or IV) who have just completed chemotherapy are invited to donate blood & urine every three months to test a new protein marker for ovarian cancer.
Contact: Carol Cherry or Honey Salador
800-325-4145

Ovarian Cancer Registry

Women with a close relative with ovarian cancer, or patients with the disease, are invited to donate personal information and blood for research.
Contact: Carol Cherry
800-325-4145

Investigation of the Biology of Ovarian Fibroblasts and Surface

This study is for women scheduled to have prophylactic removal of the ovaries. Ovarian tissue will be examined to better understand the biology of the cells and their response to drugs which may prevent ovarian cancer.
Contact: Carol Cherry or Honey Salador
800-325-4145

Study of Chemoprevention Agent for Ovarian Carcinoma

Women who have undergone genetic risk counseling and have decided with their physician to have their ovaries surgically removed may take a medication prior to surgery to see if it will alter or block cancer causing processes in the ovary.
Cecilia McAleer
800-367-6556

Biosample Repository – Banking your blood and tissue

Men and women interested in donating personal health history information and blood for ongoing cancer research may participate. With written consent, individuals having an operation or procedure at Fox Chase Cancer Center have blood or tissue banked in the Biosample Repository. Researchers use the samples from the repository to find ways to diagnose, prevent and treat cancer.
Contact: Pat Gilroy
pager # 215-401-1980